Merck (MRK) Exchange Rate Effect (2009 - 2026)

Merck (MRK) reported Exchange Rate Effect of -$19.0 million for Q1 2026, down 112.18% year-over-year from $156.0 million in Q1 2025, and down 182.61% quarter-over-quarter from $23.0 million in Q4 2025.

Merck (MRK) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Exchange Rate Effect data on file, last reported at -$19.0 million in Q1 2026.

  • Exchange Rate Effect for Q1 2026 came in at -$19.0 million, down 112.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $388.0 million (up 38700.0% YoY), and the FY2025 annual result was $563.0 million, up 292.15% from the prior year.
  • Exchange Rate Effect eased to -$19.0 million in Q1 2026 per MRK's latest filing, from $23.0 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $374.0 million in Q2 2025 and troughed at -$412.0 million in Q3 2022.
  • A 5-year average of -$8.0 million and a median of -$19.0 million in 2026 frame the typical range for Exchange Rate Effect.
  • On a YoY basis, Exchange Rate Effect climbed as much as 638.24% in 2022 and fell as far as 795.65% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $366.0 million in 2022, then slumped by 49.18% to $186.0 million in 2023, then slumped by 297.31% to -$367.0 million in 2024, then jumped by 106.27% to $23.0 million in 2025, then plunged by 182.61% to -$19.0 million in 2026.
  • Business Quant data shows MRK's Exchange Rate Effect at -$19.0 million in Q1 2026, $23.0 million in Q4 2025, and $10.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 2.70 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 67.00 Mn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn -25.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -12.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -19.00 Mn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -11.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 19.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -48.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -77.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.00 Mn
Mar 31, 2026 -19.00 Mn
Dec 31, 2025 23.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 10.00 Mn
Sep 30, 2025 10.00 Mn
Jun 30, 2025 374.00 Mn
Jun 30, 2025 374.00 Mn
Mar 31, 2025 156.00 Mn
Mar 31, 2025 156.00 Mn
Dec 31, 2024 -367.00 Mn
Dec 31, 2024 -367.00 Mn
Sep 30, 2024 294.00 Mn
Sep 30, 2024 294.00 Mn
Jun 30, 2024 -82.00 Mn
Jun 30, 2024 -82.00 Mn
Mar 31, 2024 -138.00 Mn
Mar 31, 2024 -138.00 Mn
Dec 31, 2023 186.00 Mn
Dec 31, 2023 186.00 Mn